Personalized briefing
Discovery of the day · Neurology
Antiseizure medication use in pregnancy and the risk of poor fetal growth in the EURAP international registry: a prospective cohort study
Dear Damien Boorman, this is your personalized scientific intelligence briefing — curated for your work in Neurology.
Key finding
Medicine · Neurology
Discovery of the day
This large prospective cohort study from the EURAP international registry demonstrates that prenatal exposure to antiseizure medications is associated with an elevated risk of poor fetal growth, an adverse outcome that should be considered alongside congenital malformations and neurodevelopmental effects. The researchers found that risk varies significantly across individual antiseizure monotherapies and specific drug combinations, with the risk of impaired fetal growth increasing as the number of concomitant antiseizure medications rises. For your work in preclinical models of chronic pain and your commitment to translating mechanistic insights into clinical benefit, these findings provide critical evidence for refining risk prediction and individualized treatment selection in preconception counselling for women with epilepsy.
Novelty
78%
Rigor
94%
Significance
91%
Validity
92%
Clarity
90%
Advertisement
GroupRFQ — join group deals on lab & medical equipment. Pool orders, unlock volume pricing. See open deals →
Your briefing is personalized based on your selected fields, keywords, and research interests.
